Drug Recalls

Here you'll find every drug recall the FDA has issued, including prescription medications, over-the-counter drugs, compounded pharmacy products, and dietary supplements. We've been tracking these since 2006 and our database updates several times a day so you're always looking at current information.

Drugs get recalled for a number of reasons: contamination during manufacturing, incorrect potency or dosage, failed quality testing (like dissolution or stability tests), sterility problems in injectable products, or labeling and packaging errors that could cause someone to take the wrong dose. If you find a product on this list that you use, please follow the instructions provided by the FDA to take the necessary precautions.

17,529 total recalls
2 this month

Showing 2761–2780 of 17,529 recalls

November 5, 2022· Adam's Polishes LLC

Recalled Item: Adam's Polishes ALCOHOL BASED HAND SANITIZER

The Issue: CGMP Deviations: Other lots of hand sanitizer are

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
November 5, 2022· Adam's Polishes LLC

Recalled Item: Adam's Polishes ALCOHOL BASED HAND SANITIZER

The Issue: Chemical Contamination: FDA analysis found 1 lot of

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
November 2, 2022· Direct Rx

Recalled Item: Moxifloxacin Ophthalmic Solution

The Issue: cGMP deviation: discontinue of stability support for product

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
October 21, 2022· Viatris Inc

Recalled Item: Carvedilol Tablets

The Issue: Failed Quality Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
October 18, 2022· Genentech Inc

Recalled Item: Susvimo (ranibizumab injection)

The Issue: Defective Delivery System: Commercial implants do not meet

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskTerminated
Refund
October 18, 2022· SUN PHARMACEUTICAL INDUSTRIES INC

Recalled Item: Buprenorphine and Naloxone Sublingual Tablets 8 mg/2 mg

The Issue: Presence of Foreign Substance

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
October 13, 2022· Akorn, Inc.

Recalled Item: Lidocaine Hydrochloride Jelly USP

The Issue: CGMP Deviations:

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
October 13, 2022· Akorn, Inc.

Recalled Item: Tobramycin Ophthalmic Solution

The Issue: CGMP Deviations:

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
October 13, 2022· Akorn, Inc.

Recalled Item: Ofloxacin Ophthalmic Solution

The Issue: CGMP Deviations:

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
October 13, 2022· Akorn, Inc.

Recalled Item: GONAK Hypromellose Ophthalmic Demulcent Solution

The Issue: CGMP Deviations:

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
October 13, 2022· Akorn, Inc.

Recalled Item: Levofloxacin Ophthalmic Solution 0.5%

The Issue: CGMP Deviations:

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
October 13, 2022· Akorn, Inc.

Recalled Item: Ketorolac Tromethamine Ophthalmic Solution

The Issue: CGMP Deviations:

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
October 13, 2022· Akorn, Inc.

Recalled Item: Tobramycin Ophthalmic Solution

The Issue: CGMP Deviations:

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
October 13, 2022· Akorn, Inc.

Recalled Item: Olopatadine HCl Ophthalmic Solution

The Issue: CGMP Deviations:

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
October 13, 2022· Akorn, Inc.

Recalled Item: Sodium Chloride Ophthalmic Ointment

The Issue: CGMP Deviations:

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
October 13, 2022· Akorn, Inc.

Recalled Item: Olopatadine HCl Ophthalmic Solution

The Issue: CGMP Deviations:

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
October 13, 2022· Akorn, Inc.

Recalled Item: Erythromycin Ophthalmic Ointment USP

The Issue: CGMP Deviations:

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
October 13, 2022· Akorn, Inc.

Recalled Item: Betaxolol Ophthalmic Solution

The Issue: CGMP Deviations:

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
October 13, 2022· Akorn, Inc.

Recalled Item: Olopatadine HCL Ophthalmic Solution

The Issue: CGMP Deviations:

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
October 13, 2022· Akorn, Inc.

Recalled Item: Proparacaine Hydrochloride Ophthalmic Solution

The Issue: CGMP Deviations:

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund